Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia? Stefan LeuchtMaximilian HuhnJohn M. Davis Editorial Open access 29 September 2021 Pages: 1411 - 1413
Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers Hélène VerdouxClélia QuilesNicolas Franck Original Paper 10 November 2020 Pages: 1415 - 1424
Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015 C. GlockerR. GrohmannC. Schüle Original Paper Open access 25 March 2021 Pages: 1425 - 1435
Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database Georgios SchoretsanitisEkkehard HaenMichael Paulzen Original Paper 05 April 2021 Pages: 1437 - 1443
Effects of rhythmic auditory stimulation on upper-limb movement speed in patients with schizophrenia spectrum disorders Shu-Mei WangChung-Ying LinSunny Ho-Wan Chan Original Paper 17 September 2020 Pages: 1445 - 1453
Structural alterations in brainstem, basal ganglia and thalamus associated with parkinsonism in schizophrenia spectrum disorders Stefan FritzeAnais HarneitDusan Hirjak Original Paper Open access 05 May 2021 Pages: 1455 - 1464
Neurological soft signs and cognition in the late course of chronic schizophrenia: a longitudinal study Christina J. HeroldCéline Z. DuvalJohannes Schröder Original Paper Open access 16 May 2020 Pages: 1465 - 1473
Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis Ya WangEsmee E. BraamVanessa L. Cropley Original Paper 31 August 2021 Pages: 1475 - 1485
Cortical activation abnormalities in bipolar and schizophrenia patients in a combined oddball–incongruence paradigm Lisa RauerSarah TrostOliver Gruber Original Paper Open access 24 July 2020 Pages: 1487 - 1499
Correction to: Cortical activation abnormalities in bipolar and schizophrenia patients in a combined oddball–incongruence paradigm Lisa RauerSarah TrostOliver Gruber Correction Open access 09 June 2021 Pages: 1501 - 1501
The benefits of emotionally salient cues on event-based prospective memory in bipolar patients and schizophrenia patients Simon S. Y. LuiSandy S. W. LeungRaymond C. K. Chan Original Paper 16 February 2021 Pages: 1503 - 1511
Double bookkeeping and schizophrenia spectrum: divided unified phenomenal consciousness Josef ParnasAnnick Urfer-ParnasHelene Stephensen Original Paper Open access 08 September 2020 Pages: 1513 - 1523
Insight-related beliefs and controllability appraisals contribute little to hallucinated voices: a transdiagnostic network analysis study Elisavet PappaEmmanuelle PetersVaughan Bell Original Paper Open access 14 July 2020 Pages: 1525 - 1535
Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders Manuel J. CuestaAna M. Sánchez-TorresSegPEPs Group Original Paper 07 September 2020 Pages: 1537 - 1546
Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population Maria Alice BritoAli AmadBaptiste Pignon Original Paper 10 February 2021 Pages: 1547 - 1557
Correction to: Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population Maria Alice BritoAli AmadBaptiste Pignon Correction 13 July 2021 Pages: 1559 - 1559
Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach Sandra Chi Yiu WongWing Chung ChangEric Yu Hai Chen Original Paper 25 July 2021 Pages: 1561 - 1569
Palliative and high-intensity end-of-life care in schizophrenia patients with lung cancer: results from a French national population-based study Marie VipreyVanessa PaulyGuillaume Fond Original Paper 02 September 2020 Pages: 1571 - 1578
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes Giuliana S. ZuccoliGuilherme Reis-de-OliveiraDaniel Martins-de-Souza Original Paper 10 March 2021 Pages: 1579 - 1586
Rapastinel alleviates the neurotoxic effect induced by NMDA receptor blockade in the early postnatal mouse brain Andrei-Nicolae VasilescuAnne MallienDragos Inta Short Communication 13 August 2020 Pages: 1587 - 1591
Increased PLA2 activity in individuals at ultra-high risk for psychosis Leda L. TalibAlana C. CostaWagner F. Gattaz Short Communication 06 March 2021 Pages: 1593 - 1599
